IHH Healthcare Berhad (5225) Stock Price, Fundamentals & Analysis

What 5225 does

IHH Healthcare Berhad (5225) is an investment holding company listed on the Bursa Malaysia stocks page. It operates a network of hospitals and clinics across Singapore, Malaysia, India, Greater China, Japan, Türkiye, and Europe. The company offers primary care (outpatient treatment, check-ups, vaccinations, and preventive care), secondary and tertiary care (emergencies, acute treatment, diagnostics, and lab services), and quaternary services such as organ transplants, neurosurgery, cardiac surgery, and reconstructive plastic surgery, along with complementary ancillary services.

Key numbers explained

• 8.03 MYR is the latest price per share of IHH Healthcare Berhad (5225).
• The trailing P/E ratio of 32.1 shows how much investors pay per ringgit of the last 12 months' earnings; a higher number can signal higher growth expectations.
• The forward P/E ratio of 27.2 uses expected future earnings and is often compared with the trailing P/E to judge whether the market expects growth or decline.
• 0.25 MYR is the earnings per share (EPS) over the trailing 12 months, representing the portion of profit attributable to each share.
• The dividend yield of 1.37% tells you the annual dividend as a percentage of the share price; it is a common way to compare income returns across stocks.
• 41% is the share of earnings paid out as dividends, indicating how much of the company's profit is returned to shareholders rather than kept for reinvestment.
• Beta of 0.14 suggests the stock has historically moved much less than the overall market, which is typical for large healthcare operators.
• 70.95B MYR is the market capitalisation, the total value of all outstanding shares.

What to watch

• Healthcare demand is often linked to ageing populations and government health spending, which can affect occupancy rates and pricing power.
• Regulatory changes in countries where IHH Healthcare Berhad (5225) operates, such as Malaysia, Singapore, India, and Türkiye, can influence hospital approvals, tariffs, and reimbursement rates.
• Currency movements matter because revenue is earned in several different currencies, which can affect reported growth and margins.
• The company's debt-to-equity ratio of 43.2% is a general measure of financial leverage; investors often compare it with peers such as Fresenius (FRE) or Orion (ORNBV) to gauge relative financial risk.
• Earnings reports and guidance updates, with the next report expected on Nov 25, 2026, can shift sentiment and trading volume.